Valuation: Extrawell Pharmaceutical Holdings Limited

Market Cap 204M 26.03M 22.75M 21.03M 19.43M 36.58M 2.5B 37.25M 251M 98.38M 1.22B 97.76M 95.6M 4.22B P/E 2024
-0.44x
P/E 2025 0.61x
Enterprise Value -650M -82.92M -72.46M -66.99M -61.89M -117M -7.96B -119M -799M -313M -3.9B -311M -305M -13.43B EV / Sales 2024
1.64x
EV / Sales 2025 -13.5x
Free-Float
65.45%
Yield 2024 *
-
Yield 2025 -
1 day+1.28%
1 week+9.72%
Current month+23.44%
1 month+12.86%
3 months-1.25%
6 months-18.56%
Current year-3.66%
1 week 0.07
Extreme 0.067
0.08
1 month 0.05
Extreme 0.054
0.08
Current year 0.05
Extreme 0.054
0.12
1 year 0.05
Extreme 0.054
0.15
3 years 0.03
Extreme 0.026
0.15
5 years 0.03
Extreme 0.026
0.2
10 years 0.03
Extreme 0.026
0.46
Manager TitleAgeSince
Chief Executive Officer 45 2025-12-29
Director of Finance/CFO 54 -
Corporate Officer/Principal 63 2019-06-30
Director TitleAgeSince
Director/Board Member 68 2008-10-05
Director/Board Member 63 2008-09-30
Chairman 63 2014-11-12
Date Insider Type Main position Quantity % Market Cap.
25-07-08Other

Director

139,700,000 5.8452%
Change 5-day change 1-year change 3-year change Capi.($)
+1.28%+9.72%-5.95%+49.06% 28.86M
-2.48%-6.72%+44.19%+156.43% 1,028B
-1.52%-5.01%+61.87%+58.79% 611B
-1.30%-3.88%+27.81%+79.97% 432B
-0.09%-2.54%+28.00%+21.70% 323B
-0.62%-3.21%+26.86%+43.50% 277B
+0.19%-12.91%+18.16%+21.59% 257B
+0.80%-0.19%-25.53%-39.82% 217B
-1.44%-3.49%+19.60%+56.20% 192B
-1.04%-4.63%+16.01%+68.47% 161B
Average -0.34%-3.57%+21.10%+51.59% 349.84B
Weighted average by Cap. -0.43%-5.52%+33.51%+76.92%

Financials

2024 2025
Net sales 59.1M 7.54M 6.59M 6.09M 5.63M 10.6M 724M 10.79M 72.64M 28.5M 355M 28.32M 27.7M 1.22B 55.43M 7.07M 6.18M 5.71M 5.28M 9.94M 679M 10.12M 68.13M 26.73M 333M 26.56M 25.98M 1.15B
Net income -163M -20.79M -18.17M -16.8M -15.52M -29.22M -2B -29.75M -200M -78.58M -978M -78.09M -76.37M -3.37B 223M 28.41M 24.82M 22.95M 21.2M 39.93M 2.73B 40.65M 274M 107M 1.34B 107M 104M 4.6B
Net Debt 25.4M 3.24M 2.83M 2.62M 2.42M 4.55M 311M 4.64M 31.22M 12.25M 152M 12.17M 11.9M 525M -854M -109M -95.21M -88.01M -81.32M -153M -10.46B -156M -1.05B -412M -5.12B -409M -400M -17.64B
Logo Extrawell Pharmaceutical Holdings Limited
Extrawell Pharmaceutical Holdings Ltd is an investment holding company principally engaged in the development, manufacture and sale of pharmaceuticals. The Company operates its business through three segments. The Manufacturing segment is engaged in the development, manufacture and sales of pharmaceutical products. Its self-produced products include Transfer Factor Oral Solution, Wisk, ZhouBang and others. The Trading segment is engaged in the promotion and distribution of imported pharmaceuticals. Its imported products include Millibar and Skin Cap. The Gene Development segment is engaged in the commercial development and research, development of gene-related technologies.
Employees
158
Date Price Change Volume
26-07-15 HK$0.0790 +1.28% 370,000
26-07-14 HK$0.0780 -4.88% 2,150,000
26-07-13 HK$0.0820 +17.14% 11,080,000
26-07-10 HK$0.0700 -2.78% 1,570,000
26-07-09 HK$0.0720 0.00% 3,570,000

Annual profits - Rate of surprise